Buprenorphine And Naloxone Tablet
Product Images NDC 60687-626

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 60687-626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

2 mg/0.5 mg Buprenorphine And Naloxone Sublingual Tablet Blister (2 mg 0.5 mg Blister)

2 mg/0.5 mg Buprenorphine And Naloxone Sublingual Tablet Blister (2 mg 0.5 mg Blister)
FDA Label Image

2 mg/0.5 mg Buprenorphine And Naloxone Sublingual Tablets Carton (2 mg 0.5 mg Carton)

2 mg/0.5 mg Buprenorphine And Naloxone Sublingual Tablets Carton (2 mg 0.5 mg Carton)
This is a label of Buprenorphine and Naloxone Sublingual Tablets with 2 mg/0.5 strength. It contains 50 tablets in a pack and is available only with a prescription. The NDC code is 60687-626-65, and the product should be dispersed with the provided medication for each patient.*
FDA Label Image

8 mg/2 mg Buprenorphine And Naloxone Sublingual Tablet Blister (8 mg 2 mg Blister)

8 mg/2 mg Buprenorphine And Naloxone Sublingual Tablet Blister (8 mg 2 mg Blister)
FDA Label Image

8 mg/2 mg Buprenorphine And Naloxone Sublingual Tablets Cartons (8 mg 2 mg Carton)

8 mg/2 mg Buprenorphine And Naloxone Sublingual Tablets Cartons (8 mg 2 mg Carton)
This is a description of Buprenorphine and Naloxone Sublingual Tablets. The tablets come in a pack of 50 (5 x 10) and are only available with a prescription. Each sublingual tablet contains 8 mg of buprenorphine hydrochloride and 2mg of naloxone. The usual dosage information is available in the package insert. The tablets should be kept out of reach of children and stored at room temperature. The manufacturer of the medication is R B Bt Pranmacone.*
FDA Label Image

Buprenorphine Chemical Structure (Buprenorphine Structure)

Buprenorphine Chemical Structure (Buprenorphine Structure)
FDA Label Image

Naloxone Chemical Structure (Naloxone Structure)

Naloxone Chemical Structure (Naloxone Structure)
FDA Label Image

Place Tablets Under Tongue (Image 01)

Place Tablets Under Tongue (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.